about
Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typingRevealing the history of sheep domestication using retrovirus integrationsTrachoma and Ocular Chlamydial Infection in the Era of GenomicsMass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the GambiaAssociation between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The GambiaNon-participation during azithromycin mass treatment for trachoma in The Gambia: heterogeneity and risk factorsSerology for trachoma surveillance after cessation of mass drug administrationCosts of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET studyThe Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic TreatmentAnalysis of flow cytometry data using an automatic processing tool.A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection.Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?Chlamydia trachomatis ompA variants in trachoma: what do they tell us?Estimating household and community transmission of ocular Chlamydia trachomatis.Co-evolution of genomes and plasmids within Chlamydia trachomatis and the emergence in Sweden of a new variant strain.When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countriesThe development of an age-structured model for trachoma transmission dynamics, pathogenesis and control.Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?miRNAs that associate with conjunctival inflammation and ocular Chlamydia trachomatis infection do not predict progressive diseaseHaptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children.Persistence of Innate Immune Pathways in Late Stage Human Bacterial and Fungal Keratitis: Results from a Comparative Transcriptome AnalysisProfound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communitiesBiogeography of the ecosystems of the healthy human body.Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial.Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.Diagnostic accuracy of a prototype point-of-care test for ocular Chlamydia trachomatis under field conditions in The Gambia and Senegal.Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery.Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia.Pathway-focused arrays reveal increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis.Phylogenetic analysis of Chlamydia trachomatis Tarp and correlation with clinical phenotype.Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infectionA diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles.Conjunctival transcriptome in scarring trachomaThe frequency of Chlamydia trachomatis major outer membrane protein-specific CD8+ T lymphocytes in active trachoma is associated with current ocular infection.Whole-genome enrichment and sequencing of Chlamydia trachomatis directly from clinical samplesPost-operative recurrent trachomatous trichiasis is associated with increased conjunctival expression of S100A7 (psoriasin).Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control.Conjunctival MicroRNA expression in inflammatory trachomatous scarring.The conjunctival microbiome in health and trachomatous disease: a case control study
P50
Q24601420-003F60A0-30A2-4333-8DD1-E8E162175820Q24628231-6A31F90D-97D7-41DC-822A-FFD4BC21023BQ26783635-EE581EC9-9E71-4EA0-A543-269ABA382FADQ28533873-39C21DBF-89BC-4DF5-ABF5-00C3F52A6CBAQ28534860-30810D02-A6EF-4044-B754-3DB37185A9B9Q28542612-E20DE6EF-9687-4970-A023-5E9B28F8D0CDQ28543658-FD5B033F-E6C5-4C49-BF5B-3E8C2865D055Q28546645-583EFE8B-4A3E-4B70-9781-9DFD721253DAQ28552982-51BCC9F2-A15D-4216-99ED-3D3CB1BA02E9Q31162031-0E722EA0-21F8-481B-8665-69C4A8FD4F43Q33241396-732A58FE-3D95-4BA6-9778-481014DEDD19Q33252477-D8E98320-BF35-47F6-B136-0881C6BF366AQ33372353-06230CBC-AB69-40CA-A3A7-78E9167353D2Q33424445-13FFE938-DEE6-4250-BCB3-31924BA21E77Q33449883-7BA1DF30-6D75-42AA-B598-88B0CA1B0A68Q33468389-C4821118-A1D6-466F-BA20-40D8745759D6Q33468392-11F5AF80-14A1-4666-9FEF-CCA61F82CF69Q33520204-E12536F5-3969-4D56-87DC-E7F87C43E184Q33589176-C20E0C38-8E69-4F4E-96F0-1F371C54C89EQ33605747-8E3C4FEA-5CD2-4ED5-99A6-4791200515C9Q33701142-5BDFAC88-38CA-4D8C-BD6B-30DD0380005EQ33721962-86E57B1C-823F-429A-8686-200D372A3937Q33744957-9A2EAF38-A95D-462A-83CB-D95FCD22C92BQ33745187-77710E8D-AA24-4472-8575-72FABD91801BQ33812010-59EC1890-6594-4ADF-BF9B-CD9DA2B8CED6Q33988876-9D2A1ED8-564D-40B3-908A-50260EB38694Q33994175-27719E67-DD22-4EEC-B66B-74BC15DF7094Q34002736-A206A1DF-7F9C-4E01-ADA9-D33B5A00B29EQ34022544-89261D0E-DBFB-4597-9E54-E4A4B8CEC994Q34119391-60344106-66BF-4E50-9961-D600AD6C2D03Q34290773-B4BCCD6B-BF22-4752-94FC-9437E7133B24Q34364970-80DFBB72-957A-4DC6-8DAE-1BDE9ABA65A6Q34484812-0D591C8E-BE4D-43B0-ABF7-F01A16622A03Q34491626-58BC00B9-989A-4AA8-B2F0-84FFB6DE9785Q34517521-717BD3A5-7EC6-4048-B17A-99117FCD4B99Q34535324-52CDA9EE-4422-405B-A80B-FF1DC2C507E5Q34607259-064BF913-B9CB-4A9D-9B73-1B32541EC0C0Q34611086-D2D8A2A0-B42F-425C-9307-F01F71BC399FQ34630558-85EEFCC0-A66A-45B0-AD50-DE3EAE08CFB1Q34636094-93FBA163-3591-4890-95F4-F020FD4E879B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin J Holland
@ast
Martin J Holland
@en
Martin J Holland
@es
Martin J Holland
@nl
Martin J Holland
@sl
type
label
Martin J Holland
@ast
Martin J Holland
@en
Martin J Holland
@es
Martin J Holland
@nl
Martin J Holland
@sl
prefLabel
Martin J Holland
@ast
Martin J Holland
@en
Martin J Holland
@es
Martin J Holland
@nl
Martin J Holland
@sl
P1053
K-6502-2012
P106
P21
P31
P3829
P496
0000-0002-5828-6318